| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $806.8M | -14.0% |
| R&D Expense | $534.5M | -19.8% |
| SG&A Expense | $300.9M | -9.5% |
| Operating Income | -$302.6M | +31.2% |
| Pre-tax Income | -$363.1M | +47.8% |
| Income Tax | $176K | +100.3% |
| Net Income | -$363.3M | +42.0% |
| EPS (Basic) | -$4.73 | +43.5% |
| EPS (Diluted) | -$4.73 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $779.7M | +31.3% |
| Short-term Investments | $360.0M | +27.3% |
| Accounts Receivable | $158.6M | -1.4% |
| Inventory | $23.2M | -24.1% |
| Current Assets | $1.37B | +12.1% |
| Total Assets | $1.71B | -10.1% |
| Current Liabilities | $581.0M | -3.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$107.7M | +32.0% |
| Capital Expenditures | $6.5M | -77.1% |
| Investing Cash Flow | $44.2M | +125.0% |
| Financing Cash Flow | $255.9M | -60.4% |
| Free Cash Flow | -$114.2M | +38.9% |
| +43.5% |
| Long-term Debt |
| $285.4M |
| +0.4% |
| Total Liabilities | $2.80B | +3.3% |
| Stockholders' Equity | -$1.10B | -34.1% |